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SRC proteins are non-receptor tyrosine kinases that play key roles in regulating signal transduction by a diverse set of cell
surface receptors. They contain N-terminal SH4 domains that are modified by fatty acylation and are functioning as
membrane anchors. Acylated SH4 domains are both necessary and sufficient to mediate specific targeting of SRC kinases
to the inner leaflet of plasma membranes. Intracellular transport of SRC kinases to the plasma membrane depends on
microdomains into which SRC kinases partition upon palmitoylation. In the present study, we established a live-cell
imaging screening system to identify gene products involved in plasma membrane targeting of SRC kinases. Based on
siRNA arrays and a human model cell line expressing two kinds of SH4 reporter molecules, we conducted a genome-wide
analysis of SH4-dependent protein targeting using an automated microscopy platform. We identified and validated 54
gene products whose down-regulation causes intracellular retention of SH4 reporter molecules. To detect and quantify
this phenotype, we developed a software-based image analysis tool. Among the identified gene products, we found factors
involved in lipid metabolism, intracellular transport, and cellular signaling processes. Furthermore, we identified proteins
that are either associated with SRC kinases or are related to various known functions of SRC kinases such as other kinases and
phosphatases potentially involved in SRC-mediated signal transduction. Finally, we identified gene products whose function
is less defined or entirely unknown. Our findings provide a major resource for future studies unraveling the molecular
mechanisms that underlie proper targeting of SRC kinases to the inner leaflet of plasma membranes.
[Supplemental material is available for this article.]
The SRC protein family consists of non-receptor tyrosine kinases
that play key roles in cellular signal transduction. They are in-
volved in the regulation of fundamental cellular processes in-
cluding cell growth and differentiation, as well as migration and
survival (Parsons and Parsons 2004). The general SRC kinase ar-
chitecture consists of four domains, three of which are directly
linked to the signal transduction pathways in which they are in-
volved. The SH3 domain mediates interactions with other signal-
ing molecules, the SH2 domain is required for phosphotyrosine
recognition, and the SH1 domain contains the kinase activity
(Boggon and Eck 2004). In contrast, the fourth domain (SH4) is
solely responsible for membrane attachment and targeting to
plasma membranes.
The molecular mechanism by which SRC kinases and other
peripheral membrane proteins such as Leishmania hydrophilic
acylated surface protein B (HASPB) are anchored in the inner leaflet
of plasma membranes is based on post-translational lipid modifi-
cations within their N-terminal SH4 domains. Following removal
of the N-terminal methionine residue, SH4 proteins become
myristoylated at the N terminus via an amide linkage (Resh 1999,
2004). The second acylation step involves the modification of at
least one cysteine residue by palmitoylation, resulting in a thioes-
ter linkage (Linder and Deschenes 2007). Thus, most SRC kinases
carry two binding sites for membrane anchoring. This feature has
been generalized as the two-signal hypothesis that was originally
developed for mammalian Ras proteins (Hancock et al. 1990). As
a variation of this principle, instead of palmitoylation, a second
membrane-binding site can be formed by a cluster of basic amino
acids as is the case for the prototype member of the family, SRC
(Smotrys and Linder 2004). While the enzymes involved in
N-myristoylation of SH4 domains have been known for many
years (Resh 1999), the enzymology of protein palmitoylation has
been revealed only recently with so-called DHHC (Asp-His-His-Cys)
proteins acting as S-acyltransferases (Mitchell et al. 2006; Linder
and Deschenes 2007).
N-terminal SH4 domains are sufficient for intracellular tar-
geting of, for example, GFP fusion proteins to the inner leaflet of
plasma membranes (McCabe and Berthiaume 1999; Denny et al.
2000; McCabe and Berthiaume 2001; Stegmayer et al. 2005;
Tournaviti et al. 2007, 2009). Myristoylation of SH4 domains oc-
curs cotranslationally and results in a transient insertion into in-
tracellular membranes in a perinuclear region where they colo-
calize with Golgi markers (Wolven et al. 1997; Denny et al. 2000;
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Stegmayer et al. 2005; Tournaviti et al. 2007). Recently, us-
ing semisynthetic substrates corresponding to various kinds of
palmitoylated proteins, it has been suggested that palmitoylation
of all cellular target proteins occurs specifically at the Golgi (Rocks
et al. 2010). In this way, palmitoylation appears to be controlled
spatially rather than being controlled by enzymatic specificity of
acyl transferases, an observation that is consistent with the ob-
served functional redundancy of DHHC acyl transferases that
catalyze protein palmitoylation (Hou et al. 2009).
Interestingly, palmitoylation of SH4 domains is required for
SRC kinases to properly partition into membrane microdomains
(Brown and London 1998; Webb et al. 2000; Edidin 2003; Smotrys
and Linder 2004; Linder andDeschenes 2007). This, in turn, causes
retention of SRC kinases at the level of Golgi membranes; i.e.,
forward transport to the inner leaflet of the plasma membrane is
blocked under these experimental conditions. These observations
suggest that membrane microdomains serve as sorting and trans-
port platforms required for proper targeting of SH4 proteins. Be-
sides these insights, however, our knowledge remains poor with
regard to mechanistic details of SH4-domain-dependent protein
targeting to the inner leaflet of plasma membranes.
In the present study, we have conducted an unbiased RNAi
screening approach analyzing the entire human genome for fac-
tors involved in proper targeting of SH4 proteins. We have estab-
lished an experimental model system based on two different SH4
domains that are fused to GFP and mCherry, respectively, and are
expressed simultaneously in HeLa cells in a doxycycline-de-
pendent manner. Under control conditions both of these SH4 fu-
sion proteins primarily localize to plasma membranes with only
a minor fraction being detected intracellularly. For both primary
screening and validation experiments, cells were grown on siRNA
arrays (Erfle et al. 2004; Neumann et al. 2006, 2010; Simpson et al.
2007). A software tool was developed to detect and quantify peri-
nuclear accumulation of one or both SH4 reporter molecules. Hits
identified during primary screening were validated using inde-
pendent siRNAs. All data on experimental conditions and results
of the screening procedure were stored in a web-based database.
The final list of validated gene products whose down-regulation
causes intracellular retention of SH4 reporter molecules consists of
54 gene products. It contains proteins with well-defined functions
in lipid metabolism, intracellular transport, and cellular signaling
processes, as well as other functional classes. Additionally, several
proteins were identified whose function is less defined or entirely
unknown. Thus, this study provides a major resource for studying
themechanistic details ofmicrodomain-dependentGolgi-to-plasma
membrane trafficking of SRC kinases.
Results
An experimental model system to study SH4-domain-
dependent protein targeting to plasma membranes
To study intracellular SH4-domain-dependent transport to the
plasmamembrane using a genome-wide RNAi screening approach,
we engineered a human model cell line expressing two distinct
SH4-domain-containing fusion proteins. These contained the
N-terminal 18 amino acids of either Leishmania HASPB (Denny
et al. 2000; Stegmayer et al. 2005) or of themammalian SRC kinase
YES1 (Tournaviti et al. 2009) fused to GFP (SH4-HASPB-GFP)
and mCherry (SH4-YES1-mCherry), respectively. Both fusion
proteins are substrates for N-terminal myristoylation and sub-
sequent palmitoylation (cysteine 5 in HASPB; cysteine 3 in YES1)
(Supplemental Fig. S1A). Simultaneous expression of both SH4-
HASPB-GFP and SH4-YES1-mCherry in stably transducted HeLa
cells was controlled by a doxycycline-sensitive transactivator and,
therefore, could be induced by doxycycline as demonstrated by
flow cytometry (Supplemental Fig. S1B). Upon expression, using
confocal microscopy, both reporter proteins were found to localize
at the plasma membrane establishing that N-terminal SH4 do-
mains are sufficient for proper targeting (Supplemental Fig. S2C;
McCabe and Berthiaume 1999; Denny et al. 2000; McCabe and
Berthiaume 2001; Stegmayer et al. 2005).
Palmitoylation-dependent transport of SH4 reporter proteins
to the plasma membrane
For both SH4-HASPB-GFP and SH4-YES1-mCherry, delivery to the
plasmamembrane depends on the acylation state of the respective
SH4 domain. Substitution of the myristoylated glycine residue in
SH4-HASPB not only prevents myristoylation, but also blocks
palmitoylation (McCabe and Berthiaume 1999; Denny et al. 2000;
Stegmayer et al. 2005; Tournaviti et al. 2009), i.e., N-terminal
myristoylation is a prerequisite for palmitoylation to occur. A lack
of acylation resulting from a deletion of the myristoylation site in
turn renders both SH4-HASPB- and SH4-YES1-containing fluores-
cent reporter proteins incapable of interacting with cellular
membranes, resulting in cytoplasmic localization (Fig. 1A, sub-
panels b and e). In contrast, disruption of the palmitoylation site in
HASPB does not affect myristoylation (McCabe and Berthiaume
1999; Denny et al. 2000; Stegmayer et al. 2005) and results in in-
tracellular retention at perinuclear membranes (Fig. 1A, subpanel
c). This effect ismorepronounced in case of SH4-HASPB-GFPbut can
also be observed for SH4-YES1-GFP (Fig. 1A, subpanel f). Alterna-
tively, palmitoylation can also be blocked with a non-metabolizable
palmitate analog, 2-bromo-palmitate (2-BP) (Webb et al. 2000;
Resh 2006), that inhibits transport of SH4 fusion proteins to the
plasma membrane (Fig. 1B). Again, pharmacological inhibition of
palmitoylation caused a more pronounced transport block of
SH4-HASPB-GFP when compared to SH4-YES1-mCherry (Fig. 1B).
In the context of the present study, palmitoylation-deficientmutant
forms of SH4 reporter proteins aswell as pharmacological inhibition
of SH4 palmitoylation were used as positive controls to implement
the high-content screening system as it was designed to detect and
quantify intracellular retention of SH4 fusion proteins.
A software-based image analysis tool to detect and quantify
intracellular retention of SRC kinases
Microscopy-based high-content screening approaches result in
extremely large sets of image-based data, requiring the de-
velopment of tools to achieve an efficient, unbiased, and quanti-
tative analysis of phenotypes of interest (Boland et al. 1998;
Conrad et al. 2004; Carpenter et al. 2006; Neumann et al. 2006;
Glory and Murphy 2007; Harder et al. 2008; Wang et al. 2008a;
Walter et al. 2010). Based on general tools such as cell segmenta-
tion techniques (Elowitz et al. 2002; Megason and Fraser 2007;
Wang et al. 2008b), we developed a software-based image analysis
module specifically tailored to detect and quantify intracellular
retention of SH4 fusion proteins. This software tool identifies in-
dividual cells, detects different cellular compartments, and classifies
cells according to intensity distributions between such compart-
ments (Supplemental Fig. S2). This classification can be conducted
for different fluorescence channels simultaneously, i.e., the two
different fusion proteins used in this study could be analyzed in-
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dependently. Furthermore, the software module was designed in
a way that a potential low quality of image-based screening data,
such as low resolution and out-of-focus images, local contamina-
tions, and areas of different cell densities as well as varying signal
intensities, did not result in wrong classification of phenotypes.
A crucial step for automated image analysis was the correct
identification and segmentation of individual cells since this step
provides the basis for intensity feature extractions from different
cellular areas and, therefore, has a direct impact on both quality
and reliability of the results. Cell identification was based on the
detection of stained cell nuclei by an adaptive thresholding ap-
proach. Due to the application of a stepwise convergence of in-
tensities to the intensity of cell nuclei, this approach is invariant to
different nuclear intensities between different images and there-
fore more reliable than fixed thresholding approaches. Using cell
nuclei as a seed point, the shape of individual cells was identified
by a classifier-enhanced region-growing approach. Cell boundaries
were determined by two criteria: (1) a large GFP intensity difference
between inner and outer pixels and (2) a lower GFP intensity of the
outer pixels compared to a local brightness threshold for a given cell.
These criteriawerenot only sufficient todetermine the shapeof cells
independently of the distribution of reporter intensities inside the
cell, but also provided reliable data when fluorescence intensities
varied between cells. Following determination of cell shape, cells
characterized by abnormal size and shape were classified as invalid
and excluded from further analysis. The fluorescence distribution of
the remaining cellswas used to classify the localizationof the reporter
proteins within one of three possible intracellular compartments: (1)
the nucleus, (2) the cytosol (including all membrane-compartments
that are present in the cytoplasm such as the Golgi), and (3) the
plasma membrane (Supplemental Fig. S2A). Intensity features
from the complete cell area as well as the three cellular compart-
ments were extracted and used for classification of individual cells
(Supplemental Fig. S2B). Based on these criteria, perinuclear
retention at, for example, Golgi membranes should result in an
increased cytoplasmic intensity compared to nuclear and mem-
brane-associated intensities. A detailed description of the software-
based image analysis tool used in this study is given in Methods.
Based on the use of acylation-deficient variant forms of
SH4 fusion proteins (Fig. 1A) and pharmacological inhibition
of palmitoylation using 2-BP (Fig. 1B), intracellular accumulation
of one or both reporter proteins and, therefore, redistribution of
fluorescence intensity from the plasma membrane to intracellular
compartments in individual cells was used to evaluate the image
analysis software described above. Indeed, the phenotypeof highest
interest, i.e., perinuclear retention, could be detected in ;80% of
cells expressing the HASPB palmitoylation mutant (SH4-HASPB-
Dpalm-GFP) (Fig. 1C, subpanel a). The software tool was also
capable of identifying gradual effects evoked by treatment of
cells expressing the wild-type form of SH4-HASPB-GFP with the
palmitoylation inhibitor 2-BP. Here, a range between 60%and 85%
of cells with significant perinuclear retention of SH4-HASPB-GFP
was observed depending on the inhibitor concentration applied to
the cells (Fig. 1C, subpanel b).
Automated high-content screening to identify gene products
involved in SH4-domain-dependent targeting
to plasma membranes
To identify proteins involved in SH4-domain-dependent transport
to the plasma membrane, we used siRNA arrays covering all pro-
tein-coding genes known in the human genome. Each of themore
than 21,000 genes was targeted with at least two independent
siRNAs. As described previously (Erfle et al. 2004, 2007; Neumann
et al. 2006, 2010; Simpson et al. 2007), siRNAs were immobilized
on LabTek imaging chambers in 384-spot arrays and used for
reverse transfection of a HeLa cell line stably transduced with
Figure 1. Plasma membrane targeting of SH4 fusion proteins depends
on N-terminal acylation and can be measured using an image analysis
tool. (A) Stable HeLa cells expressing GFP fusion proteins containing either
wild-type or mutant forms of the SH4 domains of either HASPB or YES1
were induced for reporter protein expression and subjected to live cell
confocal microscopy to determine the subcellular localization of the SH4
fusion proteins. (B) Stable HeLa cells expressing both SH4-HASPB-GFP and
SH4-YES1-mCherry were treated with the palmitoylation inhibitor 2-bro-
mopalmitate (2-BP). Subcellular localization of SH4 fusion proteins was
analyzed by live-cell confocal microscopy. (C ) Wide-field images from
stable HeLa cells expressing wild-type or mutant SH4 domains of HASPB
(a) or from HeLa cells expressing SH4-HASPB-GFP under treatment with
2-BP (b) were analyzed with the automated image analysis tool and
evaluated for the detection of hit phenotypes.
Novel gene products involved in SRC targeting
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SH4-HASPB-GFP and SH4-YES1-mCherry (Supplemental Fig. S1).
Thirty-six hours after transfection, expression of SH4 fusion pro-
teins was induced by doxycycline followed by live-cell imaging 48
h post-transfection (Supplemental Fig. S3). Various control siRNAs
were tested such as a scrambled siRNA and an siRNA targeting GFP
to down-regulate SH4-HASPB-GFP, as well as an siRNA to down-
regulate INCENP, an inner centromere protein whose absence is
known to cause mitotic defects and the formation of multinucle-
ated cells (Neumann et al. 2010). Indeed, reverse transfection of
a scrambled siRNA did not cause any pronounced effects on cel-
lular morphology and SH4 fusion protein localization (Supple-
mental Fig. S4A–C). In contrast, an siRNA directed against GFP
resulted in efficient silencing of the SH4-HASPB-GFP fusion protein
without any detectable effect on SH4-YES1-mCherry (Supplemental
Fig. S4D–F). Finally, as expected, siRNA-mediated down-regulation
of INCENP resulted in the appearance of enlarged and multinucle-
ated cells (Supplemental Fig. S4G–I). Thus, using the high-content
screening platform described, the expected phenotypes of control
siRNAs could be detected in a reliable manner.
Identification of candidate gene products during primary
screening
For high-content screening purposes, acquisition of experimental
data was followed by automated image analysis using a software-
based image analysis tool. This analysis was used to determine scores
as distance to the median of each 384-spot siRNA array expressed in
standard deviations (Supplemental Fig. S3). To analyze the robustness
of the system, the scores of 2286 negative controls (scrambled siRNA)
contained in the siRNA library were analyzed separately for the two
fusion proteins, SH4-HASPB-GFP and SH4-YES1-mCherry. In the case
of SH4-HASPB-GFP (Fig. 2A,E),;97%of thenegative controls did not
return scores above a threshold of 2.5. In the case of SH4-YES1-Cherry
(Fig. 2B,F), 98% of the negative controls were below a threshold of
3.5. Based on these data, scores of 2.5 for SH4-HASPB-GFP and 3.5 for
YES1-mCherry in both replicates in any of the classes of phenotypes
defined above were chosen as suitable thresholds for initial identifi-
cation of potential phenotypes. This procedure was complemented
by amanual inspection of images and resulted in the identification of
286 gene products in primary screening with a potential role in SH4-
domain-dependent protein targeting (Supplemental Table S1).
As a positive control for intracellular transport processes, the
library contained an siRNA directed against the coatomer subunit
COPB1 (Rothman 1994; Rothman andWieland 1996; Simpson et al.
2007), i.e., each 384-spot siRNA array contained up to four positive
controls. Interestingly, down-regulation of COPB1 caused strong
intracellular retention of SH4-HASPB-GFP (Fig. 2C,G); however, only
amild effect was observed for SH4-YES1-mCherry (Fig. 2D,H). Of the
898 individual experiments using an siRNA directed against COPB1,
86% showed a score above the threshold defined for SH4-HASPB-
GFP. In contrast, only 14%caused a detectable intracellular retention
of SH4-YES1-mCherry. Overall, these results indicate that the ex-
perimental system described in this study is characterized by a high
robustness and sensitivity and thus generateswell-reproducible data.
Validation and classification of gene products identified
during primary screening
Candidate gene products identified during primary screeningwere
validated using two additional siRNAs targeting different sequence
areas of the respective mRNA. This analysis was conducted in
triplicates using siRNA-coated 96-well plates (Erfle et al. 2008).
Again, reverse transfection was achieved by cultivating cells on
siRNA-coated wells for 36 h. Expression of SH4 fusion proteins was
induced by doxycycline for 12 h. Forty-eight hours post-trans-
fection, images were acquired and analyzed using the software-
based image analysis tool. Scores were calculated based on 15
negative control experiments on each plate, and thresholds were
adapted accordingly. In this set of experiments, down-regulation
of 54 target genes resulted in a score above 2 in at least two out of
three replicates (Table 1).
Validated gene products were classified with regard to function
as well as subcellular localization and membrane association (for
detailed information, visit https://ichip.bioquant.uni-heidelberg.de,
as indicated in Methods). The majority of gene products whose
RNAi-mediateddown-regulationwas found to affect SH4-dependent
targeting were membrane proteins. In addition, besides soluble
cytoplasmic proteins, a small fraction of gene products were se-
cretory proteins. As summarized in Table 1 and Supplemental Table
S2, we found factors known to be involved in, for example, protein
transport, lipid homeostasis, and protein modifications. Further-
more, several cell surface receptors and extracellular components
were identified that may affect SH4-domain-dependent trafficking
by various kinds of signaling processes.
A role of lipid homeostasis in SH4-dependent protein transport
SH4-domain-dependent trafficking was shown to depend on
cholesterol-dependent membrane microdomains (Brown and
London 1998; Webb et al. 2000; Edidin 2003; Smotrys and Linder
2004; Linder and Deschenes 2007). Consistent with that, we re-
trieved genes whose products are involved in the biosynthesis of
so-called raft lipids or in general lipid homeostasis. A prominent
example turned out to be mevalonate-diphospho-dehydrogenase
(MVD) (Toth and Huwyler 1996), an enzyme that decarboxylates
mevalonate pyrophosphate and produces isopentenyl pyrophos-
phate (activated isoprene), a critical intermediate in the bio-
synthesis of cholesterol. As shown in Figure 3A (subpanels d andh),
siRNA-mediated down-regulation of MVD caused intracellular re-
tention of both SH4-HASPB-GFP and SH4-YES1-mCherry. Similarly,
we identified sphingomyelin phosphodiesterase (acid-like 3B;
SMPDL3B) (Marchesini and Hannun 2004), which catalyzes hy-
drolysis of sphingomyelin to phosphatidylcholine and ceramide.
Again, its down-regulation inhibited transport of both SH4 fusion
proteins (Fig. 3A, subpanels c and g). Finally, we discovered acyl-
coenzyme-A dehydrogenase (ACADVL) as a gene product whose
down-regulation affects SH4-dependent trafficking. ACADVL is
a mitochondrial enzyme that catalyzes the first step in mito-
chondrial b-oxidation and is specific for very-long-chain fatty
acids. As shown in Figure 3A (subpanels b and f), its down-regula-
tion resulted in perinuclear accumulation of both SH4 fusion
proteins. Thus, we have identified three enzymes involved in lipid
metabolism, two of which directly participate in the biosynthesis
of raft lipids such as cholesterol (Simons and Ikonen 1997; Simons
and Toomre 2000; Simons and Vaz 2004) and ceramide (Bollinger
et al. 2005). Additionally, depletion of ACADVL may affect SH4-
dependent protein targeting by an indirect mechanism disturbing
lipid homeostasis.
To further validate as towhether homeostasis of cholesterol as
a raft lipid is, indeed, required for correct targeting of SH4-proteins
to the plasma membrane, we tested whether down-regulation of
MVD under the experimental conditions used causes cellular
cholesterol levels to drop. Cholesterol levels were determined by
nano-electrospray ionization mass spectrometry using phos-
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phatidylcholine (PC) as a bulk lipid to normalize data. Relative to
PC, upon treatment of cells with a siRNA targeted against MVD,
we found a reduction of cellular cholesterol by 30% (Supple-
mental Fig. S5A). Under these conditions, MVD protein levels
were reduced to;50% (Supplemental Fig. S5C), andMVDmRNA
levels were reduced by >80% (Supplemental Fig. S5B). To further
challenge the hypothesis that cholesterol homeostasis is essen-
tial for targeting of SH4-proteins to the plasma membrane, we
treated cells with methyl-b-cyclodextrin (MbCD) to deplete cel-
lular cholesterol. As indicated in Figure 3B, treatment with 5 to
10 mM MbCD resulted in pronounced intracellular retention of
SH4-HASPB-GFP as well as SH4-YES1-mCherry (Fig. 3B, sub-
panels e,f,i,j), concomitant with a reduction of cellular choles-
terol by 50% relative to PC (Supplemental Fig. S5A). These
findings are consistent with other studies in which reduction of
cholesterol levels by 30%–50% was found to have a significant
impact on cholesterol-dependent processes such as shedding
of the type XIII collagen ectodomain (Vaisanen et al. 2006). To
test whether stress potentially exerted by MbCD causes a pleio-
tropic effect on SH4-dependent protein
transport to the plasma membrane, we
treated cells with ouabain, an unrelated
inhibitor that blocks the activity of the
Na+/K+-ATPase. Similar to MbCD, this
treatment caused a mild effect on over-
all cell morphology; however, it did not
result in perinuclear accumulation of
SH4-HASPB-GFP or SH4-YES1-mCherry
(Fig. 3B, subpanels c and d). To further
analyze whether intracellular retention
was, indeed, a direct result of cholesterol
depletion, MbCD-treated cells were res-
cued by replenishment with exogenous
cholesterol. This treatment resulted in a
pronounced relocalization of both SH4-
HASPB-GFP and SH4-YES1-mCherry to the
plasmamembrane (Fig. 3B, subpanels g,h
and k,l).
Our combined findings establish
that interference with cellular choles-
terol levels results in pronounced in-
tracellular retention of SH4-proteins and
further corroborate the role of choles-
terol-dependent microdomains in SH4-
domain-dependent protein transport
to plasma membranes.
Analysis of protein kinase C alpha
as a component of SH4-domain-
dependent protein transport
Since phosphorylation of SH4-domain-
containing proteins such as SRC kinases
has been implicated in regulation of
endosomal recycling (Sandilands et al.
2004; Sandilands and Frame 2008;
Tournaviti et al. 2009), another interest-
ing result of this study was the identifi-
cation of members of the protein kinase
C family of serine/threonine kinases. As
shown in Figure 4A, concomitant with
reduction of PRKCA protein levels to ;20% compared to a treat-
ment with a scrambled siRNA (Fig. 4B; Supplemental Fig. S5D),
siRNA-mediated down-regulation of PRKCA caused perinuclear
accumulation of SH4 fusion proteins. This effect was not de-
pendent on the fluorescent reporter protein fused to the respec-
tive SH4-domain, as knockdown of PRKCA in stable cell lines
expressing either SH4-HASPB-mCherry (Supplemental Fig. S6A,
subpanel c) or SH4-YES1-GFP (Supplemental Fig. S6A, subpanel f)
also resulted in an intracellular retention. To test whether PKC ac-
tivity is required for plasma-membrane targeting of SH4-proteins,
stable HeLa cells were treated with the protein kinase C inhibitor
GO¨ 6983, resulting in pronounced intracellular retention of both
SH4-HASPB-GFP (Fig. 4C, subpanel c) and SH4-YES1-GFP (Fig.
4C, subpanel d).
These findings indicate that protein phosphorylation by PKC
plays an important role in SH4-domain-dependent protein trans-
port; however, it remains to be clarified whether PRKCA directly
targets SH4 domains or whether other substrates of this kinase are
affecting SH4-dependent trafficking.
Figure 2. Robustness and sensitivity of the experimental system at the level of primary screening.
Stable HeLa cells were cultivated on 384-well siRNA arrays for 36 h, followed by the induction of ex-
pression of SH4-HASPB-GFP and SH4-YES1-mCherry. Nuclei were labeled and cells were subjected to
live cell fluorescence microscopy in areas of immobilized siRNAs. Enlarged image details from primary
screening data after transfection of a scrambled siRNA (A,B) and an siRNA targeted against the coatomer
subunit COPB1 (C,D) are shown. Scores of all individual control experiments from primary screening
were calculated using the image analysis tool described and are shown for SH4-HASPB-GFP (E,G ) and
SH4-YES1-mCherry (F,H ), respectively. Negative controls (scrambled siRNA) are shown in panels E and
F. Positive controls (siRNA targeted against COPB1) are shown in panels G and H. Scores below the
defined hit threshold lie between the dashed lines within the gray shaded area.
Novel gene products involved in SRC targeting
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Table 1. Validated gene products with a putative function in SH4-domain-dependent intracellular trafficking
Gene symbol Entrez gene ID RefSeq siRNA ID
Antisense siRNA
sequence SH4-HASPB-GFP SH4-YES1-mCherry
Lipid metabolism
ACADVL 37 NM_000018 s208 AAACUGUUCAUUGACAAUCcc 3.4 6.1
MVD 4597 NM_002461 s224074 UUUUUAACUGGUCCUGGUGca 2.8
SMPDL3B 27293 NM_014474 s26101 UGCUAUGACGCGAUGAUGCtt 5.0
SREBF2 6721 NM_004599 s28 UUUGACCUUUGCAUCAUCCaa 2.1
Transport factors
COPA 1314 NM_004371 s3369 AAAGCGAGUUUUCUCAUCCtt 7.6 5.5
COPB1 1315 NM_016451 s3371 UGGAUUAGCAUGACAGACCtt 7.0 4.2
s3372 UCUUUGACUUUACAUCUCCtt 6.1 2.6
KIF20B 9585 NM_016195 s18420 UCGAUAUUCUUUAACUUGCtt 2.6
s18421 UGCUGAACUAAUACGUUUGgg 2.6
RAN 5901 NM_006325 s11768 UUCUUGUAAGUAACUCUCGat 6.5
s11769 UUUCCUGUCCUUAAUAUCCac 4.8
Protein phosphorylation
PRKCA 5578 NM_002737 s11093 UGCGGAUUUAGUGUGGAGCgg 4.3 3.3
PRKCB 5579 NM_212535 s11096 AAAUCGGUCAGUUUCAUCCgg 3.3 2.6
PTPRD 5789 NM_001040712 s11540 UACAUUCGCGUAUCUAUUCtt 2.4
Other protein modifications
ACY3 91703 NM_080658 s40752 UUCGCGAUUAAGCAGGUGCcc 2.8 3.2
GALNTL4 374378 NM_198516 s51536 AAAGUUGUCAUAUUUGAUGtt 2.7
LIPT2 387787 XM_370636 s226411 AAUUGAGAAAUGACAAUCUat 5.0 5.3
NAA35 60560 NM_024635 s34135 UUUACGUACUUUGCCGUCCat 3.9 3.4
Membrane receptors
BAI3 577 NM_001704 s1878 UGGAUUGCUAAGCUCAUUCat 3.2
CDH26 60437 NM_021810 s34067 AGCAGGAGUAGAGUGUAUGtt 3.1 2.8
IL7R 3575 XM_001127146 s7325 UGGUUAGUAAGAUAGGAUCca 2.5 3.5
ITGAV 3685 NM_002210 s7569 UAGGGUACACUUCAAGACCag 4.9 7.1
ITGB1 3688 NM_002211 s7575 AGCCGUGUAACAUUCCUCCag 4.4 3.2
s7576 UAAUCGCAAAACCAACUGCtg 5.0 3.2
s7574 UGCUGUUCCUUUGCUACGGtt 3.6
LILRB5 10990 NM_006840 s21637 AAAAAGAAAGUGUCUAUCUga 2.4
OR10V1 390201 NM_001005324 s52738 UCAGGGUCAGGUGAGAAUGga 2.9 2.5
TGFBR1 7046 NM_004612 s14073 AGUCUUUCAACGUAGUACCct 5.0
Gene regulation and expression
EIF4A3 9775 NM_014740 s18876 UUCACGAACCUGAAUAUCCaa 3.3 3.9
s18877 UGAUCUGCUUGAUUGCUCGtt 4.5 4.0
HNRNPA1 3178 NM_002136 s6710 UUAUCUGGUACCAUUAUUCaa 2.4
RPS26P35 441377 XM_496991 s54340 UCUUUAAGAACUCAGCUCCtt 3.4
RPL21P62 442160 XM_001128707 s54494 UAACUUGUUUGUUUACAACaa 2.8
RPS26P8 644191 XM_930072 s55596 UCACAUACAGUUUGGGAAGca 2.7
MBD3L2 125997 NM_144614 s42925 UGGAUUUCUCGUUUCUUCUgt 3.6
RPL23AP82 284942 NM_203302 s49770 UCAGGACAAAUCAGGGUGGtg 3.2 2.3
PHF5A 84844 NM_032758 s39506 AUAGGAGUCACAAAUCACAca 4.2 3.5
POLR2F 5435 NM_021974 s224297 UGGCAGGUAACGGCGAAUGat 3.7 2.9
s10809 UGUGGUGAUUCGCUUCUGGtt 2.7
PRPF8 10594 NM_006445 s20796 UCGUUGUUCACAUGUAGGGca 5.1 8.2
s20797 AUGCGAUCAAUGUAUCUGCag 3.7 6.8
PRPF31 26121 NM_015629 s25122 UACUUAUCCCGGAUGAACUta 2.5
RPL18 6141 NM_000979 s194744 UAUAACUUGACCAACAGCCtc 3.7
s194745 UAGGAUCCAGGGUUAGUUUtt 3.0
RPL21 6144 NM_000982 s12186 UAUCUCGGCUCUUAGAGUGct 3.0
s12187 UAACAUUGUAGACUCUUCCag 2.9
RPS25P6 401206 XM_937380 s53508 UAAGUUAUUGAGCUUGUCCcg 3.8 3.8
SF3A1 10291 NM_001005409 s20117 UCAAUAUCCAGACCUGGUGcg 2.8
ZNF326 284695 NM_182975 s195972 UUCCAUUAAAGCCCUGAUAag 2.4
Others
A2M 2 NM_000014 s819 UCGUUCUUAACCAUCACUGtg 3.2 2.9
ATP6AP2 10159 NM_005765 s19790 UUUCGGAAAACAACAGACCct 2.3
CACNA1S 779 NM_000069 s2297 UUCCGGUUUAUUUGGGUCCca 4.1
CHERP 10523 NM_006387 s20627 UUUGUUCUCUUCUCCGAGCct 2.8 3.1
DBH 1621 NM_000787 s3947 ACUGUGACCACCUUUCUCCca 2.7
CDC37P1 390688 NM_001080829 s52851 UCUUCAUCAUCGCUCAGUGtg 2.9
MAGEB1 4112 NM_002363 s8455 UUUAUACUUACGUAGAAUGaa 2.3
SHC1 6464 NM_003029 s12811 AAAUGAGAUAGAUUGCAUGtg 4.0
(continued)
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Analysis of coatomer as a component
of SH4-domain-dependent protein targeting
As mentioned above, COPB1 (b-COP) is a subunit of the coatomer
complex that was identified and validated to be required for proper
targeting of SH4 fusion proteins (Fig. 2; Table 1; Supplemental
Table S2). Since the coatomer is a hetero-heptameric complex, we
further evaluated the COPB1 phenotype based on the assumption
that coatomer is required as a protein complex, i.e., coatomer
subunits other than COPB1 should give a similar phenotype when
down-regulated byRNA interference. In a first step, we extended our
studies to ARCN1 (d-COP) (Fig. 5A) and assessed down-regulation of
both COPB1 and ARCN1 by quantitative Western blotting (Fig.
5B). These studies established efficient down-regulation at the
protein level of each subunit by the respective siRNA to ;40% or
even below 20%, respectively (Supplemental Fig. S5E). As can be
expected for a stoichiometric protein complex, down-regulation of
COPB1 also caused a loss of ARCN1, and vice versa. As shown in
Figure 5A, down-regulation of ARCN1 resulted in a pronounced
intracellular retention of SH4-HASPB-GFP, while targeting of
SH4-YES1-mCherry was only mildly affected. These differential
effects were not caused by the different fluorescent reporter pro-
teins fused to the SH4 domains of HASPB and YES1, since stable
HeLa cells expressing SH4-HASPB-mCherry (Supplemental Fig.
S6A, subpanel b) also showed strong intracellular retention of the
SH4 fusion protein upon down-regulation of COPB1. Similarly,
knockdownofCOPB1 in stableHeLa cells expressing SH4-YES1-GFP
resulted in amild retention of the SH4 fusion protein (Supplemental
Fig. S6A, subpanel e). These studies were further extended toward
COPA (a-COP) and COPB2 (b9-COP), two additional subunits
of coatomer. Again, following transfection of the corresponding
siRNAs, strong intracellular retention was observed for SH4-HASPB-
GFP (Supplemental Fig. S6B, subpanels a,d) but only amild effect on
targeting of SH4-YES1-mCherry (Supplemental Fig. S6B, subpanels
b,e). To address whether intracellular retention evoked by knock-
down of coatomer subunits was, indeed, a result of depletion of
the coatomer protein complex, we microinjected stable HeLa cells
expressing SH4-HASPB-mCherrywith recombinant coatomer before
transfection with siRNAs targeted against COPB1. Indeed, targeting
of SH4 fusion proteins was unaffected in cells that were micro-
injectedwith coatomer, demonstrating a role for coatomer in proper
targeting of SH4-HASPB-GFP; however, it does not appear to play an
essential role in targeting of SH4-YES1-mCherry (Fig. 5C).
Coatomer and PRKCA as components in plasma membrane
transport of endogenous YES1 and other SH4 proteins
To address whether our experimental system is capable of identify-
ing components required for transport of endogenous SH4 proteins,
we analyzed the localization of endogenous YES1 after knockdown
of the factors identified and validated in this study. Transfection of
siRNAs directed against COPB1 (Fig. 6A, subpanels d–f) and PRKCA
(Fig. 6A, subpanels g–i) not only resulted in an intracellular re-
tention of SH4-HASPB-mCherry, but also affected plasma mem-
brane targeting of endogenous YES1 visualized by immunolabel-
ing with specific antibodies. We further analyzed whether the
identified components required for plasmamembrane targeting of
HASPB and YES1 also affected transport of other SH4-domain-
containing proteins. Among those were other members of the SRC
family kinases (SFKs) such as SRC (non-palmitoylated), LCK and
FYN (both dually palmitoylated) (Shenoy-Scaria et al. 1993; Koegl
et al. 1994; Resh 1994), whose SH4 domains were expressed as GFP
fusion proteins in stable HeLa cells (Tournaviti et al. 2007, 2009).
Upon down-regulation of COPB1 and PRKCA, we observed differ-
ential effects on targeting of the different SH4 fusion proteins.
RNAi-mediated down-regulation of COPB1 (Fig. 6B, subpanels d–f)
resulted in an enhanced intracellular retention of SH4-LCK-GFP
and SH4-SRC-GFP; however, it did not influence plasma mem-
brane targeting of SH4-FYN-GFP. Knockdown of PRKCA (Fig. 6B,
subpanels g–i) caused strong intracellular accumulation of SH4-
LCK-GFP and also affected the localization of SH4-SRC-GFP. Again,
transport of SH4-FYN-GFP was not affected. These findings sup-
port previous data showing that different SH4-domain-containing
proteins localize to different subcellular membranes and traffic
along different routes, often dependent on the acylation pattern
present in the respective SH4 domain (Shenoy-Scaria et al. 1994;
Sandilands et al. 2004; Kasahara et al. 2007). The finding that both
coatomer and PRKCA exert effects on SH4-LCK-GFP and SH4-SRC-
GFP but do not affect transport of SH4-FYN-GFP, which is directly
targeted to the plasma membrane without passing through the
Golgi system, may indicate that both factors play a role in SH4-
dependent transport at the level of the Golgi or the endosomal
system.
Besides the examples given above and as documented in Table
1 and Supplemental Table S2, we were also able to identify gene
products with so far unknown functions. Additionally, gene
products were identified that are likely to have a rather indirect
impact on SH4-domain-dependent targeting such as factors regu-
lating gene expression. This observation is also consistent with
a relatively large number of factors that localize to the nucleus.
Discussion
SRC kinases and other peripheral membrane proteins contain ac-
ylated SH4 domains that mediate both association with mem-
branes and proper targeting to specific subcellular membranes.
While the physical association of SH4 domains withmembranes is
understood in great detail, their role in intracellular sorting and
Table 1. Continued
Gene symbol Entrez gene ID RefSeq siRNA ID
Antisense siRNA
sequence SH4-HASPB-GFP SH4-YES1-mCherry
SOBP 55084 NM_018013 s30136 AAGUAGUUCGCAGUUAUUCtt 3.4 3.5
TMEM126A 84233 NM_032273 s38695 AAUCCAGUAACUUAAGAUGtt 2.1
YAP1 10413 NM_006106 s20367 UGAUUUAAGAAGUAUCUCUga 2.2
Unknown
PATE2 399967 NM_212555 s53217 UAAUGAUACAUGCUCUGCCct 3.4 3.6
C12orf36 283422 NM_182558 s49233 UAGUGGAGCAUGAAGUGUCtt 3.0
C16orf71 146562 NM_139170 s44876 UCUGGAAUCAGGGAGGUUUgg 3.2
FAM108A1 81926 NM_001130111 s230886 UUAAUUUCCGUUUUCACGUat 2.2
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plasma membrane targeting as well as the function of membrane
microdomains in this process is poorly understood. The aim of the
present study was to conduct a global analysis of the human ge-
nome to reveal gene products involved in SH4-domain-dependent
plasma membrane targeting of acylated proteins, such as SRC ki-
nases. Stable cell lines were engineered that express two different
kinds of SH4 fusion proteins in a doxycycline-dependent manner.
An experimental system was developed to detect and quantify in-
tracellular retention of SH4 proteins,
whichwas combinedwith siRNA arrays to
individually down-regulate every single
gene known in the human genome. Live-
cell imaging was conducted using an au-
tomated wide-field microscopy platform.
Using a software-based image analysis
tool, intracellular retention of SH4 fusion
proteins could be detected and quantified
for each individual experimental condi-
tion of down-regulation of a specific gene
product. The two different SH4 fusion
proteins were analyzed independently in
order to identify potential differences in
SH4-dependent trafficking depending on
the individual properties of a given SH4
domain.
To characterize the experimental
system described, we reasoned that gen-
eral components of intracellular trans-
port might be required for targeting of
SH4 fusion proteins. More specifically,
since all palmitoylated proteins have
been proposed to contact the Golgi
(Rocks et al. 2010), we hypothesized that
the heterooligomeric coatomer complex
may play a role in SH4-dependent traf-
ficking. Indeed, siRNA-mediated down-
regulation of the COPB1 gene consis-
tently resulted in perinuclear retention of
SH4 fusion proteins. We further con-
cluded that down-regulation of coatomer
subunits that exist in just one isoform
(e.g., COPA, COPB1, COPB2, and ARCN1
[d-COP]) (Wegmann et al. 2004) should
result in a similar phenotype, which was
indeed the case. In addition, we could
show that down-regulation of single
coatomer subunits affected protein levels
of other subunits as well and, hence,
most likely results in a destabilization of
the complete coatomer complex. More-
over, RNAi-mediated down-regulation of
endogenous coatomer subunits did not
affect SH4-dependent trafficking when
cells were microinjected with recom-
binant coatomer. Therefore, using our
experimental system, we were able to
identify COPB1 as a component of a
multi-protein complex, which plays an
important role in SH4-dependent protein
transport.
Another protein whose down-regu-
lation caused a pronounced effect on
SH4-dependent protein transport was a protein kinase, PRKCA.
Moreover, using a pharmacological inhibitor of protein kinase C,
we could demonstrate a requirement for protein kinase C activity
in correct targeting of SH4 proteins to the plasma membrane.
Whether SH4 domains are direct targets for phosphorylation by
PRKCA or whether other target proteins play direct roles in SH4-
domain-dependent protein transport remains a subject for further
investigation.
Figure 3. Interference with cellular lipid metabolism by RNAi-mediated down-regulation of meta-
bolic enzymes or pharmacological cholesterol depletion causes intracellular retention of SH4 proteins.
(A) HeLa cells expressing SH4-HASPB-GFP and SH4-YES1-mCherry were reverse-transfected with a
scrambled siRNA (a,e) and siRNAs targeted against acyl-coenzyme A-dehydrogenase, very long chain
(ACADVL) (b,f ), sphingomyelin phosphodiesterase, acid-like, 3B (SMPDL3B) (c,g), and mevalonate
(diphospho) decarboxylase (MVD) (d,h) and subjected to live-cell fluorescence microscopy. Enlarged
image details from original data from the validation screen are shown. (B) HeLa cells expressing SH4-
HASPB-GFP and SH4-YES1-mCherry were treated with methyl-b-cyclodextrin (MbCD) to deplete cel-
lular cholesterol and analyzed by live-cell confocal microscopy to determine the subcellular localization
of SH4 fusion proteins. Subsequently, the same cells were supplemented with cholesterol and analyzed
by live-cell confocal microscopy again. Control cells were treated with 50 mM ouabain and analyzed by
live-cell confocal microscopy.
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Regarding further requirements of SH4-dependent traffick-
ing, a major result of this study was the identification of enzymes
that play key roles in lipid biosynthesis and homeostasis. Among
those was a key factor of cholesterol biosynthesis, MVD, the en-
zyme that generates activated isoprene. Down-regulation of MVD,
indeed, caused reduced cellular cholesterol levels that were corre-
lated with intracellular accumulation of SH4 proteins. Further-
more, pharmacological depletion of cellular cholesterol also inhibi-
ted transport of SH4 proteins, an effect that could be reversed upon
replenishment with exogenous cholesterol. Taken together, our
findings corroborate the role of cholesterol-dependent membrane
microdomains in SH4 trafficking (McCabe and Berthiaume 1999,
2001; Webb et al. 2000; Tournaviti et al. 2009). They are further
consistent with other large-scale RNAi approaches, suggesting that
RNAi-mediateddown-regulationofMVDaffects cholesterol-dependent
processes such as Dengue virus replication (Rothwell et al. 2009).
Another interesting observation of this studywas differences
between the two SH4 domains used as targeting motifs. Com-
Figure 4. Characterization and validation of PRKCA as a component in
SH4-dependent protein transport. (A) HeLa cells expressing SH4-HASPB-
GFP and SH4-YES1-mCherrywere transfectedwith a scrambled siRNA (a–c),
and a siRNA directed against PRKCA (d–f ), and subjected to live-cell con-
focal microscopy to determine the localization of both SH4 fusion pro-
teins. (B) Equal protein amounts of total cell lysates from transfected and
induced cells were subjected to SDS-PAGE and Western blot analysis with
antibodies directed against GFP, PRKCA, and GAPDH. (C ) Stable HeLa
cells expressing SH4-HASPB-GFP (a,c), or SH4-YES1-GFP (b,d ), were cul-
tured in the presence of 10mMprotein kinase C inhibitor GO¨ 6983 for 16 h
(c,d ), and analyzed by live-cell confocal microscopy for subcellular local-
ization of both SH4 fusion proteins.
Figure 5. Characterization and validation of coatomer as a component
in SH4-dependent protein transport. (A) HeLa cells expressing SH4-
HASPB-GFP and SH4-YES1-mCherry were transfected with a scrambled
siRNA (a–c), siRNAs directed against COPB1 (d–f ) and ARCN1 (g–i ), and
subjected to live-cell confocal microscopy to determine the localization of
both SH4 fusion proteins. (B) Equal protein amounts of total cell lysates
from transfected and induced cells were subjected to SDS-PAGE and
Western blot analysis with antibodies directed against GFP, COPB1,
ARCN1, andGAPDH. (C ) HeLa cells expressing SH4-HASPB-mCherry were
coinjected with recombinant coatomer and an Alexa-488-labeled sec-
ondary antibody before transfection with a siRNA directed against COPB1.
Thirty hours post-transfection, cells were analyzed by live-cell confocal
microscopy to determine the subcellular localization of the SH4 fusion
protein in microinjected cells.
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pared to the YES1 SH4 domain, down-regulation of coatomer
subunits had a much more pronounced inhibitory effect on
plasma membrane targeting of a fusion protein containing the
SH4 domain of HASPB, indicating differential requirements
depending on different kinds of SH4 domains. Consistently,
factors involved in transport of those two SH4 domains were
shown to have differential effects on fusion proteins containing
SH4 domains of other SRC kinases, such as LCK, SRC, and FYN, as
well as on endogenous YES1. Differential transport requirements
are also evident from the complete list of validated gene products
shown in Table 1 and Supplemental Table S2. Of the 54 gene
products shown to play a role in SH4-dependent trafficking, 13
were found to function primarily in HASPB targeting, 18 ap-
peared to be specific for YES1 targeting, and 23 were found to be
required for both transport processes. These observations are
generally consistent with earlier findings from other groups
suggesting the existence of multiple pathways of SH4 trafficking
(Sato et al. 2009). Furthermore, our data show that the experi-
mental model system is not only suited to identify general com-
ponents involved in SH4-dependent transport processes but also
reveals differential requirements when different SH4 domains are
directly compared. These findings also directly exclude potential
pleiotropic effects and emphasize the capability of the experi-
mental system to reveal differences between various kinds of
SH4-dependent trafficking.
The 54 gene products validated in this study to play a role
in SH4-domain-dependent protein targeting were classified into
eight groups according to experimentally shown or annotated
functions (Table 1; Supplemental Table S2). As expected, we found
several membrane receptors as well as kinases and phosphatases
whose down-regulation affects SH4-dependent trafficking. Besides
gene products involved in the formation or the removal of other
post-translational modifications as well as a relatively large group
of gene products involved in the regulation of gene expression,
we also revealed four gene products whose functions are entirely
unknown.
It is clear that the present screening approach cannot be
considered as comprehensive since obviously a number of gene
products that are known to play a role in SH4-dependent targeting
were not returned as hits. For example, we could not identify
a single DHHC protein, the enzymes that mediate palmitoylation
of SH4 proteins (Smotrys et al. 2005; Mitchell et al. 2006). In the
light of recent findings, it is clear that this phenomenon is due to
functional redundancy within the family of DHHC proteins (Hou
et al. 2009; Rocks et al. 2010), making it impossible to evoke
a phenotype by down-regulation of individual members of the
DHHC family. In this sense, the siRNA screening effort presented
in this study cannot be considered as an attempt to identify all
gene products that play a role in SH4-dependent protein targeting
but rather provides amajor resource of a subgroup of proteins with
non-redundant functions in this process.
Methods
Generation of stable HeLa cell lines expressing acylated SH4
fusion proteins
Constructs encoding acylated fluorescent reporter proteins (SH4-
YES1-mCherry, SH4-HASPB-GFP [see Supplemental Material 1],
SH4-YES1-GFP, SH4-HASPB-mCherry, SH4-LCK-GFP, SH4-SRC-GFP,
SH4-FYN-GFP) were cloned into the retroviral expression vector
pRevTRE2. Following retroviral transduction of HeLa cells, con-
structs were stably inserted into the target genome followed by the
isolation of cell lines using fluorescence-activated cell sorting as
described previously (Engling et al. 2002). Doxycycline-dependent
expression of the respective SH4 fusion proteins was confirmed by
analytical flow cytometry.
Figure 6. PRKCA and coatomer play differential roles in transport of
endogenous YES1 and other SH4 proteins. (A) Stable HeLa cells
expressing SH4-HASPB-mCherry were transfected with a scrambled
siRNA (a–c), and siRNAs directed against COPB1 (d–f ) and PRKCA (g–i ),
and induced for reporter protein expression. Forty-eight hours post-
transfection, cells were fixed, subjected to immunostaining against en-
dogenous YES1, and subsequently analyzed by confocal microscopy. (B)
Stable HeLa cells expressing fusion proteins of the SH4 domains of the
acylated SRC kinases LCK, SRC, and FYN were transfected with a scram-
bled siRNA (a–c), and siRNAs directed against COPB1 (d–f ) and PRKCA
(g–i ). Forty-eight hours post-transfection, cells were analyzed by live-cell
confocal microscopy to determine the subcellular localization of the re-
spective SH4-protein.
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Analysis of the subcellular localization of SH4 fusion proteins
using live-cell confocal and wide-field fluorescence microscopy
HeLa cells were cultivated on eight-well LabTek imaging chambers
(Nunc) and induced to express fluorescent SH4 fusion proteins by
cultivation in thepresenceof 1mg/mLdoxycycline for 12 to 24h. To
inhibit protein palmitoylation, cells were cultivated in the presence
of 2-bromopalmitate (2-bromohexadecanoic acid) (Sigma-Aldrich).
Cells were cultivated in the presence of the protein kinase C in-
hibitor GO¨ 6983 (Sigma-Aldrich) for 16 h. Thirty minutes prior to
imaging, themediumwas replaced byprewarmedCO2-independent
medium (Invitrogen), and cells were analyzed on an LSM 510 con-
focal microscope (Zeiss), an Axiovert fluorescence wide-field mi-
croscope (Zeiss), or a Scan^R screening microscope (Olympus).
Genome-wide primary screening for factors involved
in subcellular localization of acylated SH4 fusion proteins
Genome-wide primary screening was conducted by reverse trans-
fection of cells with an siRNA library (Ambion) consisting of about
52,000 siRNAs targeting all genes known in the human genome
(Ensembl version 27) with at least two siRNAs per gene. This siRNA
library was arranged in 384-spot siRNA arrays (Erfle et al. 2004,
2007; Neumann et al. 2006, 2010; Simpson et al. 2007). Per array,
120,000 cells were seeded and, 36 h post-transfection, expression
of SH4 fusion protein was induced by incubation of cells for 12 h
in the presence of 1 mg/mL doxycycline. Growth medium was
replaced by prewarmed CO2-independent medium (without
phenol-red) (Invitrogen) containing 0.2 mg/mL Hoechst 33342
(Sigma-Aldrich) for labeling of cell nuclei. Forty-eight hours post-
transfection, siRNA arrays were loaded onto an Olympus Scan^R
screening microscope with a 37°C incubation chamber, and im-
ages from the GFP, Cherry, and Hoechst channel were acquired
by automated live-cell fluorescence microscopy at 103 magnifi-
cation. Images were analyzed using the image analysis tool de-
scribed below.
Validation of gene products identified
during primary screening
Validation screening was conducted by reverse transfection of
a newly designed siRNA library consisting of 776 silencer select
siRNAs (Ambion) targeting 286 human genes. Validation was con-
ducted on siRNA-coated 96-well plates (Erfle et al. 2008) in four rep-
licates. Four thousand cells were seeded per well using a FlexDrop
system (Perkin Elmer). Thirty-six hours post-transfection, SH4 fu-
sion protein expressionwas induced by cultivation in the presence
of 1 mg/mL doxycycline for 12 h. Growth medium was replaced
by prewarmed CO2-independent medium (without phenol-red)
(Invitrogen) containing 0.2mg/mLHoechst 33342 (Sigma-Aldrich)
to label cell nuclei. Forty-eight hours post-transfection, siRNA-
coated 96-well plates were loaded onto an Olympus Scan^R
screening microscope with a 37°C incubation chamber, and two
images per well were acquired for each channel by automated live-
cell fluorescence microscopy at 103 magnification. Images were
analyzed using the image analysis tool described below.
A software-based image analysis tool to detect and quantify
intracellular retention of SH4 fusion proteins
Based on general techniques to analyzemicroscopy-based imaging
data such as cell segmentation (Elowitz et al. 2002; Megason
and Fraser 2007; Wang et al. 2008b), an image analysis tool
was developed to automatically detect and quantify intracellular
retention of SH4 fusionproteins as a desired phenotype. To achieve
optimal cell detection, cell nuclei were segmented by Hoechst
staining in a first step as a prerequisite for cell segmentation
(Rosenfeld et al. 2005; Gordon et al. 2007). Since intensity values
of nuclei in any given Hoechst image were within a certain range,
thresholding techniques could be applied (Wu et al. 2000).
However, due to varying nuclear intensities within the complete
screening data set, an adaptive thresholding technique was re-
quired for reliable determination of cell nuclei. Starting with
a high value, the threshold was gradually decreased until the
size of segmented nuclei was consistent with the assumed size. In
an additional step, segmented nuclei were post-processed, re-
moving local contaminations and other artifacts in the region
of the nucleus.
Segmented cell nuclei were the basis of a classifier-enhanced
region growing method used to segment complete cells. This
method requires a seed point provided by cell nuclei and a criterion
to detect cell boundaries, which was achieved by a rule-based
classifier. The classifier uses both local cell brightness in the area of
the nucleus and a gradient of fluorescence intensities across the
whole area of the cell. The cell boundary is recognized when the
brightness of an inspected pixel is below theminimal brightness in
the area of the nucleus and the gradient magnitude is above a cer-
tain threshold. This approach is suitable to segment the whole cell
area and allows for the detection of changes of gradient magni-
tudeswithin the cytoplasm,which is the casewhen the fluorescent
reporter protein accumulates in a perinuclear region, a distribution
indicative for localization in Golgi membranes or recycling endo-
somes. An important feature of thismethod is its ability to segment
cells independently of local brightness. Due to the choice of nuclei
as seed points and the methodology to detect cell boundaries, it
was possible to detect individual cells with similar fluorescence
intensities even when multiple cells formed direct plasma mem-
brane contacts. Additionally, cell clusters with overlapping cell
boundarieswere detected by the proximity of their nuclei andwere
excluded from further analysis.
Cell segmentation was finally used to define three cellular re-
gions, the nucleus, the cytoplasm and the cell boundary. To detect
the cell boundary, the difference between the original and
an eroded cell segmentation result was determined. Following
the determination of the nucleus and the cell boundary, the
remaining cellular area was defined as the interior of the cell
along with all organelles such as the Golgi that are embedded in
the cytoplasm. Ratios of mean values and standard deviations of
each cell and its constituent parts were calculated for brightness-
invariant classification of phenotypes. This was achieved using
a decision tree based on the analysis of the extracted features for all
phenotypes.
Calculation of scores from classification results derived
from the automated image analysis tool
Results of cell classification were subjected to further analysis to
calculate scores. The percentage of cells displaying a classified
phenotype was determined for each image. In the validation
screening procedure, cells from both images of the same well were
combined for further analysis. Both the median and the standard
deviation of a complete array were calculated and used to de-
termine a score for each experimental condition. This score was
expressed as the distance in standard deviations to the median of
the respective 384-spot siRNA array. In validation screening, the
median and standard deviation fromall negative controls analyzed
on the same plate were used for the determination of scores. In
primary screening, the hit threshold for SH4-HASPB-GFPwas set to
a score of 2.5 for both replicates and to 2 (3/4 or 2/3 replicates) in
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validation screening. For potential hits from the so-called drug-
gable genome, SH4-HASPB-GFP hits were included in the valida-
tion screening procedure when the hit threshold was above 5 on
only one replicate. The hit threshold for SH4-YES1-Cherry was
adjusted to a score of 3.5 in primary screening (both replicates) and
2 in validation screening (3/4 or 2/3 replicates). All potential hits
derived from primary screening that were identified with the
automated image analysis tool were further subjected to manual
inspection.
Liquid-phase transfection of stable HeLa cells with siRNAs
directed against MVD, coatomer subunits, and PRKCA
Stably transducedHeLa cells were transfected with siRNAs directed
against MVD (Ambion, s9094), the coatomer subunits COPA
(Ambion, 146404), COPB1 (Ambion, 24546), COPB2 (Ambion,
137699), ARCN1 (Ambion, 10234), and a siRNA directed against
PRKCA (Ambion, s11093) as well as a scrambled siRNA (Ambion,
103860 or neg. control #1) in 24-well plates using oligofectamine
(Invitrogen). For each well, 50 pmol of siRNA was preincubated
with 12 mL of diluted (1:4) oligofectamine for 20 min at room
temperature before addition to cells. Thirty-two to 36 h post-
transfection, cells were passaged and cultivated in eight-well
LabTek imaging chambers (Nunc). Expression of SH4 fusion pro-
teins was induced by cultivating cells in the presence of 1 mg/mL
doxycycline for 12–18 h. For MVD knockdowns, cells were culti-
vated in DMEM containing 10% delipidated FCS (PAN Biotech).
Quantification of RNAi-mediated knockdown efficiencies
of MVD, coatomer subunits, and PRKCA using Western blot
analysis and quantitative real-time PCR
Stable HeLa cells expressing SH4-HASPB-GFP and SH4-YES1-
mCherry were transfected with a scrambled siRNA (Ambion,
103860) and siRNAs directed against GFP (Ambion, 4626), MVD
(Ambion, s9094), COPB1 (Ambion, 24546), and ARCN1 (Ambion,
10234) or PRKCA (Ambion, s11093) on six-well plates using 300
pmol of siRNA. For MVD knockdowns, cells were cultivated in
DMEM containing 10% delipidated FCS (PAN Biotech). Twenty-
four hours post-transfection, reporter protein expression was in-
duced by cultivation in the presence of 1 mg/mL doxycycline for
a further 24 h. Forty-eight hours post-transfection, cells were har-
vested. For Western blot analysis, 60 mg of total protein from the
post-nuclear supernatant was subjected to SDS-PAGE on NuPAGE
4%–12% gradient gels (Invitrogen). Gels were blotted on PVDF
membranes, and specific proteins were detected using polyclonal
antibodies raised againstGFP,MVD (SantaCruz, sc-160550), COPB1,
and ARCN1 and mouse monoclonal antibodies against PRKCA
(Abcam, ab31) and GAPDH (Ambion, 4300). Signals were detected
and quantified using a LICOR infrared imaging system. For real-time
PCR, RNA was extracted using the RNeasy Mini Kit (QIAGEN) and
used for cDNA synthesis applying the ImProm-II Reverse Tran-
scription System (Promega). Using the TaqMan Gene Expression
assay (Ambion, Hs00159403_m1), mRNA levels were determined
using a StepOne Real-Time PCR System (Applied Biosystems).
Depletion of cellular cholesterol and cholesterol rescue
Stable HeLa cells were incubated for 20 h in the presence of 1 mg/
mL doxycycline to induce expression of SH4-HASPB-GFP and
SH4-YES1-mCherry in DMEM containing 10% delipidated FCS
(PAN Biotech). For cholesterol depletion, cells were incubated for 1
h in the presence of 5–10 mM methyl-b-cyclodextrin (MbCD)
(Sigma-Aldrich) before analysis by live-cell confocal microscopy.
Subsequently, for cholesterol replenishment, water-soluble choles-
terol (Sigma-Aldrich) was added to the MbCD-treated cells in a 1:10
ratio (0.5 mM cholesterol to 5 mM MbCD-treated cells and 1 mM
cholesterol to 10 mM MbCD-treated cells) and incubated for 1.5 h
before analysis by live-cell confocal microscopy. Control cells were
incubated for 20 h with 50 nM ouabain in DMEM containing 10%
delipidated FCS and analyzed by live-cell confocal microscopy.
Immunostaining of stable HeLa cells
Stable HeLa cells grown on coverslips were fixed in 5% PFA for 5
min at room temperature, quenched in 50 mM NH4Cl for 5 min,
and permeabilized in 0.1%TX-100 for 5min before blocking in 1%
BSA for 1 h. Endogenous YES1 was labeled by incubation with
a specific antibody (BD, 610375) diluted 1:250 in 1% BSA for 1 h.
Samples were incubated with a Alexa488-labeled secondary anti-
body (Invitrogen) diluted 1:1000 in 1% BSA for 1 h and mounted
in LinMount (Linaris) mounting medium.
Microinjection of recombinant coatomer
Recombinant coatomer (;1.3 mg/mL) (Sahlmuller et al. 2011) or
the respective buffer was co-injected with 1:10 diluted Alexa488-
labeled secondary antibodies (Invitrogen) into stable HeLa cells
using a FemtoJet microinjection device (Eppendorf) mounted on
an Axiovert 35 microscope (Zeiss). Three to 6 h after microinjec-
tion, cells were transfected with a siRNA against COPB1 (Ambion,
24546) and induced for reporter protein expression 4 h post-
transfection. Cells were analyzed by live-cell confocal microscopy
30 h after transfection.
Determination of cellular cholesterol levels using
nano-electrospray ionization mass spectrometry
Stable HeLa cells were cultivated in DMEM containing 10%
delipidated FCS (PANBiotechGmbH) and transfectedwith a siRNA
directed against MVD (Ambion, s9094) for 48 h or treated with 10
mM methyl-b-cyclodextrin (Sigma-Aldrich) for 30 min. Control
cells were cultivated in normal DMEM (untreated) or in DMEM
containing 10% delipidated FCS (mock). Either whole cells or
membranes isolated by ultracentrifugation of postnuclear super-
natants from homogenized cells were subjected to lipid extraction
and mass spectrometric quantification of cholesterol and PC as
described previously (Merz et al. 2011).
Data access
All original data along with analysis results derived from this study
have been stored in twoweb-based databases. They can be accessed
at https://ichip.bioquant.uniheidelberg.de (User: ‘‘ichipguest’’; Pass-
word: ‘‘Dec5ex2h’’) and http://www.mitocheck.org/cgi-bin/mtc.
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